Navigation Links
Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery
Date:11/16/2010

CHICAGO, Nov. 16, 2010 /PRNewswire-FirstCall/ -- New results from an observational substudy from TRITON–TIMI 38 presented today at the American Heart Association (AHA) Scientific Sessions annual meeting showed that patients treated with Effient® (prasugrel) prior to coronary artery bypass graft surgery (CABG) had a reduced overall mortality rate compared to patients treated with Plavix® (clopidogrel) (2.3 percent versus 8.7 percent respectively, p=0.016).(1)  

This retrospective analysis involved 346 patients with acute coronary syndrome (ACS) who had received either study drug and subsequently underwent isolated CABG at some point during the 15-month TRITON-TIMI 38 trial.(2)

In addition to all-cause mortality, this same analysis found that the risk-adjusted rate of cardiovascular death at 30 days was also lower in patients treated with Effient compared with those receiving clopidogrel (0.6 percent versus 5.8 percent respectively, p=0.038). (3) Effient-treated patients experienced a statistically significantly higher volume of chest tube blood loss at 12 hours post-CABG compared to the clopidogrel-treated patients (655 +/- 580 milliliters with Effient versus 503 +/- 378 milliliters with clopidogrel).(1)

"This analysis showed that Effient was associated with a significantly lower mortality rate compared with clopidogrel among these CABG patients but with a significantly higher risk of serious bleeding events," said Peter K. Smith, M.D., professor of surgery and division chief of Cardiovascular and Thoracic Surgery at Duke University Medical Center and lead investigator for the retrospective CABG analysis. "This analysis helps better define the risk of mortality for physicians who care for the ACS patients who may be targeted for percutaneous coronary intervention (PCI) but end up undergoing CABG instead."

The Effient prescribing information includes a warning and precaution against starting Effient in patients like
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Study Shows Use of AdvanDxs PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections
2. n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
3. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa
4. Unemployment, Health Care Spending Affect Mortality
5. Increased Mortality Associated With Nocturia
6. Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
7. Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection
8. Robotic Prostatectomy Expert Dr. David Samadi Talks About Big Strides in the Fight Against Prostate Cancer - Mortality Rate Declines 45%
9. Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
10. Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 20, 2015 Research and ... the "Global Pressure Relief Devices Market 2015-2019" ... Relief Devices market to grow at a CAGR of ... Pressure Relief Devices Market 2015-2019, has been prepared based ... experts. The report covers the Americas, and the APAC ...
(Date:7/27/2015)... 27, 2015  Attorney Advertising-- Bronstein, Gewirtz & Grossman, ... purchasers of the securities of AMAG Pharmaceuticals Inc. ... investors are advised to contact Peretz Bronstein ... Kimelman at info@bgandg.com or 212-697-6484. ... certain of its officers and/or directors have violated ...
(Date:7/27/2015)... , July 20, 2015 Research and Markets ... "Medical Device Regulation in Asia/Pacific Markets Seminar" ... the European Medical Device market is well established, the ... China , together with other countries ... the process of implementing, their own medical device regulations. ...
Breaking Medicine Technology:Global Pressure Relief Devices Market 2015-2019 with ArjoHuntleigh, Hill-Rom, Paramount Bed Holdings & Stryker Dominating 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals Inc. 2Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2
... Myocor, Inc. announced that,the U.S. Food and ... Valvular and Ventricular Improvement Via iCoapsys Delivery ... evaluate the,safety and feasibility of the percutaneously ... valve insufficiency caused by left,ventricular dysfunction and ...
... Senesco,Technologies, Inc. ("Senesco" or the "Company") (Amex: ... lab studies at Mayo Clinic focused,on multiple myeloma. ... Factor 5A gene technology to up-regulate apoptosis of ... for,encapsulation of Factor 5A to enhance the time ...
Cached Medicine Technology:Myocor Receives Approval for Percutaneous Trial 2Senesco Technologies Initiates Preclinical Studies for Cancer Target 2
(Date:7/27/2015)... NJ (PRWEB) , ... July 27, 2015 , ... ... entitled "Applying Data To Reduce Hospital Readmissions." , The Centers for Medicare and ... facility-level data used as part of their penalty calculation. Known as the QualityNet ...
(Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they know that ... loss can incur a lot of stress, pain, discomfort and embarrassment, which is why ... All-On-4™ treatment reaps the benefits of implants with the cost savings of dentures for ...
(Date:7/27/2015)... ... , ... According to an article published by the Times Free Press ... stemming from intravenous drug use. Intravenous drug use causes more overdoses and is responsible ... including Hepatitis B and C and HIV. Drug treatment facilities in Tennessee have witnessed ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... of fullerenes in medical and diagnostics applications is rapidly increasing and is driven ... and cancer treatment, they are increasingly being evaluated for use in bio implants. ...
(Date:7/27/2015)... ... ... Sher Fertility Institute, a national network of fertility clinics known ... their clinical team in Las Vegas. , Dr. Mark Severino joins ... Endocrinology teams in the region. , Combined Drs. Sher and Severino have more than ...
Breaking Medicine News(10 mins):Health News:BESLER Consulting Publishes E-book Focused on Reducing Hospital Readmissions 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 2Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 3Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 2Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 3Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 2Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 3
... the risk of developing breast cancer, says a new ... between handedness// and incidence of breast cancer in over ... 1941, reports science portal EurekAlert. ,They recorded ... economic status, smoking habits, family history of breast cancer, ...
... Wake Forest University Baptist Medical Center have begun a ... synthetic steroids to prevent premature babies//., ,Premature infants ... fully developed. Currently the best treatments are to give ... for as long as possible. ,Sheep will ...
... designed a plastic device which helps in prevention of ... patients//. The scarring in these cancer patients hinders the ... to reduce the risk of scarring in women undergoing ... ,Joan Thomas, is Macmillan Nurse specialist who has ...
... chemicals has been known to be associated with health ... But it is known not until recently that rheumatoid ... to mineraloil., ,The exact causative factor rheumatiod factor ... and environmental fcators have been help responsible to a ...
... might help lower the negative impact on a person's blood ... that job strain had a significant impact, both clinically and ... low marital cohesion, or a lack of support from a ... of blood pressure over one year. High marital cohesion in ...
... to lose the excess weight that one has to carry like ... best way is that adopted earlier that is the basic principle ... Obesity is a big problem these days., ,Calorie counting ... towards weight control., ,With so many dietary plans jostling for ...
Cached Medicine News:
Full plate covers seal all 24 MicroAmp tubes...
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Inquire...
... A soft, heat-resistant, aluminum foil film ... AlumaSeal II minimizes evaportaion and vapor ... need for heat-sealing devices or mats. ... sovents and reagents. Compared to other ...
Medicine Products: